Catalyst Wire Dossier Catalyst Wire Dossier

Ruxolitinib IR

ruxolitinib · Incyte Corporation
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Ruxolitinib IR, covering 2025-02-13 to 2025-02-13. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate the Bioequivalence of Ruxolitinib Extended Release (XR) Tablets With Ruxolitinib Immediate Release (IR) Tablets Administered Orally in Healthy Participants [Phase 1]

See pricing